Connect with us

Technology

DuPont Reports Second Quarter 2026 Results

Published

on

Exceeds Second Quarter 2026 Guidance

Raises Full Year 2026 Guidance

Second Quarter 2026 Highlights

Net Sales of $1.8 billion increased 4%; organic sales increased 4% versus year-ago periodGAAP Income from continuing operations of $191 million; operating EBITDA of $448 millionGAAP EPS from continuing operations of $1.37; adjusted EPS of $1.88Cash provided by operating activities from continuing operations of $400 million; transaction-adjusted free cash flow of $326 million representing 127% conversionAnnounces intent to repurchase $250 million of shares in the third quarterAnnounces the Company’s Global Industry Classification Standard (GICS) code has changed to Industrials effective July 31, 2026

WILMINGTON, Del., Aug. 4, 2026 /PRNewswire/ — DuPont (NYSE: DD) announced its financial results(1) for the second quarter ended June 30, 2026 and raised financial guidance for the full year 2026. 

“We delivered another strong quarter, exceeding our financial guidance and demonstrating our focus on consistent execution” said Lori Koch, DuPont Chief Executive Officer. “Mid-single digit organic growth, strong margin expansion, coupled with robust adjusted EPS growth and free cash flow generation underscore the strength of our market-leading businesses and reflect disciplined execution of our strategic priorities, supported by our ongoing focus on excellence and productivity.”

“We are delivering on our commitments, creating value for all of our key stakeholders and further strengthening the foundation for sustainable, long-term profitable growth,” Koch concluded.

Second Quarter 2026 Consolidated Results(1)

Dollars in millions, except EPS

2Q’26

2Q’25

Change

vs. 2Q’25

Organic Sales (2)

vs. 2Q’25

Net sales

$1,819

$1,749

4 %

4 %

GAAP Income from continuing operations

$191

$24

n.m.

Operating EBITDA(2)

$448

$423

6 %

Operating EBITDA margin(2) %

24.6 %

24.2 %

40 bps

GAAP EPS from continuing operations

$1.37

$0.17

n.m.

Adjusted EPS(2)

$1.88

$1.27

48 %

Cash provided by operating activities – cont. ops.

$400

$74

n.m.

Transaction-adjusted free cash flow(2)

$326

$107

205 %

Net sales

Net sales were up 4% on a 4% increase in organic sales.4% organic sales growth in Healthcare & Water Technologies; 3% organic sales growth in Diversified Industrials.

GAAP Income from continuing operations

GAAP Income/GAAP EPS from continuing operations improved on higher segment earnings and lower interest expense and transaction costs.

Operating EBITDA

Operating EBITDA increased on organic growth and productivity.

Adjusted EPS

Adjusted EPS increased on higher segment earnings, lower net interest expense and a lower tax rate.

Cash provided by operating activities from continuing operations

Cash provided by operating activities from continuing operations in the quarter of $400 million, capital expenditures of $76 million and separation-related transaction costs and other payments of $2 million resulted in transaction-adjusted free cash flow and related conversion of $326 million and 127%, respectively.

(1)

Results and cash flows are presented on a continuing operations basis. See page 6 for further information, including the basis of presentation included in this release.

(2)

Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS, transaction-adjusted free cash flow and transaction-adjusted free cash flow conversion are non-GAAP measures and only reflect continuing operations. See page 6 for further discussion, including a definition of significant items. Reconciliation to the most directly comparable GAAP measure, including details of significant items begins on page 13 of this communication.

 

Second Quarter 2026 Segment Highlights

Healthcare & Water Technologies

Dollars in millions

2Q’26

2Q’25

Change

vs. 2Q’25

Organic Sales(2)

vs. 2Q’25

Net sales

$856

$817

5 %

4 %

Operating EBITDA

$258

$248

4 %

Operating EBITDA margin %

30.1 %

30.4 %

(30) bps

Net sales

Net sales increased 5% on organic sales growth of 4% and a currency benefit of 1%.Healthcare Technologies sales up mid-single digits on an organic basis on broad-based growth led by personal protection and biopharma.Water Technologies sales up low-single digits on an organic basis on continued strength in industrial water and semiconductor markets, partially offset by weakness in the Middle East.   

Operating EBITDA

Operating EBITDA increased on organic growth and productivity, partially offset by growth investments.Operating EBITDA margin of 30.1% decreased 30 basis points as organic growth and productivity were more than offset by less favorable mix and growth investments.

Diversified Industrials

Dollars in millions

2Q’26

2Q’25

Change

vs. 2Q’25

Organic Sales(2)

vs. 2Q’25

Net sales

$963

$932

3 %

3 %

Operating EBITDA

$213

$199

7 %

Operating EBITDA margin %

22.1 %

21.4 %

70 bps

Net sales

Net sales increased 3% on organic sales growth in the quarter.Building Technologies sales up low-single digits on an organic basis due to growth in residential and non-residential construction markets.Industrial Technologies sales up mid-single digits on an organic basis on continued strength in aerospace coupled with growth in electric vehicle applications.

Operating EBITDA

Operating EBITDA and margin increased on organic growth, favorable mix and productivity.

2026 Financial Outlook

Dollars in millions, except EPS

2H’26E

Full Year 2026E

Net sales

$3,660 – $3,690

$7,160 – $7,190

Operating EBITDA(2)

$890 – $910

$1,750 – $1,770

Adjusted EPS(2)

$3.65 – $3.80

$7.17 – $7.32

“Our strong execution and market-driven growth continue to translate into higher earnings and free cash flow generation. As a result of our second quarter outperformance, we are again raising the midpoint of our full-year 2026 operating EBITDA guidance to approximately $1.76 billion and adjusted EPS guidance to $7.24 per share, while increasing our expectation for organic sales growth to slightly above 4%,” said Antonella Franzen, DuPont Chief Financial Officer.

“With continued strength across healthcare, industrial water, and aerospace end-markets, we expect mid-single digit organic sales growth in the second half and remain focused on driving profitable growth and value creation for shareholders.” Franzen concluded.

Conference Call

The Company will host a live webcast of its quarterly earnings conference call with investors to discuss its results and business outlook beginning today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DuPont’s Investor Relations Events and Presentations page. A replay of the webcast also will be available on the DuPont’s Investor Relations Events and Presentations page following the live event.

About DuPont

DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPontTM and all products, unless otherwise noted, denoted with TM, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.

Overview

On May 26, 2026, DuPont’s Board of Directors announced a reverse stock split of the Company’s common stock, par value $0.01 per share, at a ratio of 1-for-3, as well as a reduction in the number of authorized shares of its common stock by a corresponding ratio (the “Reverse Stock Split”), as approved by shareholders. The Reverse Stock Split became effective on June 24, 2026. All share and share-related information presented in these interim Consolidated Financial Statements has been retroactively adjusted in all periods presented to reflect the decreased number of shares resulting from the Reverse Stock Split and related impacts.

On April 1, 2026, DuPont completed the sale of the Aramids business (the “Aramids Business” and the divestiture of the Aramids Business, the “Aramids Divestiture”) to Arclin, a portfolio company of an affiliate of TJC LP for pre-tax cash proceeds of approximately $1.2 billion, subject to customary transaction adjustments, a note receivable in the principal amount of $300 million (the “Aramids Note Receivable”) and a non-controlling common equity interest (the “Aramids Equity Consideration”), valued at $325 million, in New Arclin U.S. Holding Corp., which now owns the Arclin global materials business and the Aramids Business. The financial results of the divested Aramids Business are reflected in DuPont’s interim Consolidated Financial Statements as discontinued operations, along with comparative periods.

On November 1, 2025, DuPont completed the separation of its semiconductor and interconnect solutions businesses (the “Electronics Business” and the separation of the Electronics Business, the “Electronics Separation”) into an independent public company, Qnity Electronics, Inc. (“Qnity”), by way of the distribution to DuPont’s stockholders of record as of October 22, 2025 of all the issued and outstanding common stock of Qnity on November 1, 2025 (the “Qnity Distribution”). As a result, the financial results of the divested Electronics Business are reflected in DuPont’s interim Consolidated Financial Statements as discontinued operations for all periods.

Cautionary Statement Regarding Forward-looking Statements

Certain statements in this release may be considered forward-looking statements, within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often contain words such as “expect”, “anticipate”, “intend”, “plan”, “believe”, “seek”, “see”, “will”, “would”, “target”, “outlook”, “stabilization”, “confident”, “preliminary”, “initial”, “continue”, “may”, “could”, “project”, “estimate”, “forecast” and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which are beyond DuPont’s control, that could cause actual results to differ materially from those expressed in any forward-looking statements.

Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont’s actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to (i) the ability to realize the intended benefits of the Electronics Separation and the Qnity Distribution, including achievement of the intended tax treatment, contractual allocation to, and assumption by Qnity of certain liabilities, including certain legacy liabilities with respect to per- and polyfluoroalkyl substances (“PFAS”) and the possibility of disputes, litigation or unanticipated costs in connection with the Electronics Separation and Qnity Distribution; (ii) the impact of the Aramids Divestiture on DuPont’s balance sheet, financial condition and future results of operations; (iii) risks and costs related to the impact of the arrangement to share future eligible PFAS costs by and among DuPont, Corteva, Inc. and The Chemours Company, including the outcome of pending or future litigation related to PFAS or PFOA, which includes personal injury claims and natural resource damages claims; the extent and cost of ongoing and potential future remediation obligations; and changes in laws and regulations applicable to PFAS chemicals; (iv) the failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with the Electronics Separation, the Aramids Divestiture and completed and future, if any, divestitures, mergers, acquisitions, and other portfolio management, productivity and infrastructure actions; (v) risks and uncertainties that are outside the Company’s control but adversely impact the overall environment in which DuPont, its customers and/or its suppliers operate, including changes in economic, political, regulatory, international trade, geopolitical, military conflicts, capital markets and other external conditions, including pandemics and responsive actions, as well as natural and other disasters or weather-related events; (vi) the ability to offset increases in cost of inputs, including raw materials, energy and logistics; (vii) the risks and uncertainties associated with continuing or expanding geopolitical conflicts or trade disputes or restrictions and responsive actions, new or increased tariffs or export controls, including on exports to China of U.S.-regulated products and technology; (viii) other risks to DuPont’s business and operations, including the risk of impairment; (ix) risks and uncertainties in connection with completing the $2 billion share buyback announced on November 6, 2025, including timeline, associated costs and the possibility that the authorization may be suspended or discontinued prior to completion; (x) the ability to realize the intended benefits of the Reverse Stock Split; (xi) the impact of the invalidation of certain tariffs imposed under the International Emergency Economic Powers Act and (xii) other risk factors discussed in DuPont’s most recent annual report on Form 10-K, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with the U.S. Securities and Exchange Commission.

Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Non-GAAP Financial Measures

Unless otherwise indicated, all financial metrics presented reflect continuing operations only.

This communication includes information that does not conform to accounting principles generally accepted in the United States of America (“U.S. GAAP”) and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company, including allocating resources. DuPont’s management believes these non-GAAP financial measures are useful to investors because they provide additional information related to the ongoing performance of DuPont to offer a more meaningful comparison related to future results of operations. These non-GAAP financial measures supplement disclosures prepared in accordance with U.S. GAAP, and should not be viewed as an alternative to U.S. GAAP. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these Non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page 12. Non-GAAP measures included in this communication are defined below. The Company has not provided forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of certain future events. These events include, among others, the impact of portfolio changes, including asset sales, mergers, acquisitions, and divestitures; contingent liabilities related to litigation, environmental and indemnifications matters; impairments and discrete tax items. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.

Key Terms

Significant Items

Significant items are items that arise outside the ordinary course of business for the Company and includes items for nonconsolidated affiliates, that the Company’s management believes may cause misinterpretation of underlying business and investment performance, both historical and future, based on a combination of some or all of the item’s size, unusual nature and infrequent occurrence. Management classifies as significant items certain costs and expenses associated with integration and separation activities related to transformational acquisitions and divestitures as they are considered unrelated to ongoing business performance. There were no significant items associated with nonconsolidated affiliates recorded for the three and six month periods ended June 30, 2026 and June 30, 2025.

Future Reimbursable Indirect Costs

Indirect costs, such as those related to corporate and shared service functions previously allocated to the separated Electronics Business and Aramids Business, do not meet the criteria for discontinued operations and are reported within continuing operations in all respective periods presented. The Company has, is, will or expects to be reimbursed in accordance with the applicable transition service agreements (“TSAs”) for the portion of indirect costs related to activities the Company is, will or expects to undertake on a transitional basis to support a) Qnity not beyond year end 2027 for services and 2040 for site leases and, b) the Aramids Business post the Aramids Divestiture, but not beyond 2028 (such indirect costs “Future Reimbursable Indirect Costs”). Services provided and costs reimbursed in accordance with the applicable TSAs include but are not limited to, costs associated with information technology services/support, product stewardship and regulatory support, facilities services, and shared property lease costs.

Future Reimbursable Indirect Costs do not meet the criteria for discontinued operations and therefore are included in both GAAP Net Income from Continuing Operations and in GAAP Cash provided by operating activities-continuing operations for all periods presented. Future Reimbursable Indirect Costs are excluded from Adjusted Earnings, Operating EBITDA and Transaction-Adjusted Free Cash Flow, each defined below. Such indirect costs that are not subject to future reimbursement are reported within continuing operations in Corporate and are included within Adjusted Earnings, Operating EBITDA, and Cash provided by operating activities-continuing operations.

Corporate DDOB Remediation Costs

Corporate DDOB Remediation Costs are environmental remediation costs, including certain investigate, remediate and restoration costs, associated with discontinued or divested operations, businesses or product lines (“Corporate DDOB Remediation Costs”). DDOB Remediation Costs are excluded from Adjusted Earnings and Operating EBITDA, as defined below, to provide better insight into the underlying business performance of the Company.

Non-GAAP Measure Definitions

Organic Sales

Organic Sales is defined as net sales excluding the impacts of currency and portfolio.

Adjusted Earnings

Adjusted Earnings is defined as income from continuing operations excluding the after-tax impact of significant items, after-tax impact of amortization expense of intangibles, the after-tax impact of non-operating pension / other post employment benefits (“OPEB”) credits / costs, Future Reimbursable Indirect Costs and Corporate DDOB Remediation Costs.

Adjusted Earnings is the numerator used in the calculation of Adjusted EPS, as well as the denominator in Adjusted Free Cash Flow Conversion.

Adjusted EPS

Adjusted EPS is defined as Adjusted Earnings per common share – diluted. Management estimates amortization expense in 2026 associated with intangibles to be about $275 million on a pre-tax basis, or approximately $1.54 per share.

Operating EBITDA, EBITDA Margin & Incremental Margin

The Company’s measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company’s chief operating decision maker (“CODM”) assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., “Income from continuing operations before income taxes”) before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, Corporate DDOB Remediation Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.

Operating EBITDA Margin is defined as Operating EBITDA divided by Net Sales.

Incremental Margin is the change in Operating EBITDA divided by the change in Net Sales for the applicable period.

Adjusted Free Cash Flow & Adjusted Free Cash Flow Conversion

Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company’s business nor reflect the Company’s underlying business liquidity. As a result, Adjusted Free Cash Flow represents cash that is available to the Company, after investing in its asset base, to fund obligations using the Company’s primary source of liquidity, cash provided by operating activities from continuing operations. Management believes Adjusted Free Cash Flow, even though it may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company’s cash flow and financial performance, and it is an integral measure used in the Company’s financial planning process. Management notes that there were no exclusions for items that are unusual in nature and/or infrequent in occurrence for the three and six month periods ended June 30, 2026.

Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow divided by Adjusted Earnings. Management uses Adjusted Free Cash Flow Conversion as an indicator of our ability to convert earnings to cash.

Transaction Adjusted Free Cash Flow & Transaction Adjusted Free Cash Flow Conversion

Management believes supplemental non-GAAP financial measures including Transaction-Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow Conversion (each defined below) provide an integral view of information on the Company’s underlying business performance during this period of transformational change. Management believes the Electronics Separation and Aramids Divestiture collectively represent a significant transformational change for the Company and separation-related transaction cost payments impact comparability to the Company’s continuing operations. Management believes Transaction-Adjusted Free Cash Flow, which may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company’s cash flow and financial performance, and it is an integral measure used in the Company’s financial planning process. These non-GAAP financial measures are not intended to represent residual cash flow for discretionary expenditures since other non-discretionary expenditures, such as mandatory debt service requirements, are not deducted from the measure.

Transaction-Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and removing the impact of separation-related transaction costs and other payment and cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company’s business nor reflect the Company’s underlying business liquidity.

Transaction-Adjusted Free Cash Flow Conversion is defined as Transaction-Adjusted Free Cash Flow excluding separation-related transaction costs, divided by Adjusted Earnings.

Separation-related transaction costs and other payments include cash outflows directly associated with the Electronics Separation and the Aramids Divestiture. These costs include advisor and banking fees, payments related to establishing a new capital structure (including fees associated with interest rate swaps), capital expenditures required to facilitate physical asset separation, restructuring payments associated with senior leadership, and Future Reimbursable Indirect Costs, among other expenditures.

Future Reimbursable Indirect Costs are excluded from Adjusted Earnings and Operating EBITDA. To provide comparable data analysis, the Company has also adjusted payments associated with Future Reimbursable Indirect Costs within Separation-related transaction costs and other payments. This adjustment is intended to provide insight into the Company’s underlying business performance. For the six months ended June 30, 2026, the Company adjusted $8 million associated with Future Reimbursable Indirect Costs within Separation-related transaction costs and other payments.

Additionally, $2 and $5 million were reflected in Separation-related transaction costs and other payments for the three and six month periods ended June 30, 2026, respectively, for capital expenditures incurred to complete the physical separation of shared locations.

Finally, $6 million of restructuring and short-term incentive program payments to former senior leadership were reflected in Separation-related transaction costs and other payments for the six month period ended June 30, 2026. These payments were reflected in other cash payments as they related to the establishment of the post-spin leadership structure.

DuPont de Nemours, Inc.

Consolidated Statements of Operations

Three Months Ended
June 30,

Six Months Ended

June 30,

In millions, except per share amounts (Unaudited)

2026

2025

2026

2025

Net sales

$    1,819

$    1,749

$    3,500

$    3,361

Cost of sales

1,180

1,143

2,259

2,212

Research and development expenses

42

53

89

103

Selling, general and administrative expenses

269

262

524

496

Amortization of intangibles

68

74

136

149

Restructuring and asset related (benefits) charges – net

(3)

—

43

39

Acquisition, integration and separation costs

7

55

7

105

Equity in earnings (loss) of nonconsolidated affiliates

9

9

8

(6)

Sundry income (expense) – net

42

(9)

78

91

Interest expense

41

84

81

167

Income from continuing operations before income taxes

$      266

$        78

$      447

$      175

Provision for income taxes on continuing operations

75

54

106

71

Income from continuing operations, net of tax

$      191

$        24

$      341

$      104

(Loss) income from discontinued operations, net of tax

(44)

46

(30)

(615)

Net income (loss)

$      147

$        70

$      311

$     (511)

Net income attributable to noncontrolling interests

4

11

7

19

Net income (loss) available for DuPont common stockholders

$      143

$        59

$      304

$     (530)

Per common share data:

Earnings per common share from continuing operations – basic

$     1.38

$     0.17

$     2.45

$     0.73

(Loss) earnings per common share from discontinued operations – basic

(0.32)

0.25

(0.22)

(4.53)

Earnings (loss) per common share – basic

$     1.05

$     0.42

$     2.23

$    (3.80)

Earnings per common share from continuing operations – diluted

$     1.37

$     0.17

$     2.43

$     0.73

(Loss) earnings per common share from discontinued operations – diluted

(0.32)

0.25

(0.22)

(4.52)

Earnings (loss) per common share – diluted

$     1.05

$     0.42

$     2.22

$    (3.79)

Weighted-average common shares outstanding – basic

135.9

139.6

136.3

139.6

Weighted-average common shares outstanding – diluted

136.8

139.9

137.2

139.9

 

DuPont de Nemours, Inc.

Condensed Consolidated Balance Sheets

In millions, except share amounts (Unaudited)

June 30, 2026

December 31, 2025

Assets

Current Assets

Cash and cash equivalents

$                  1,740

$                    715

Restricted cash and cash equivalents

42

42

Accounts and notes receivable – net

1,751

1,669

Inventories

1,210

1,172

Prepaid and other current assets

113

121

Assets of discontinued operations

—

1,856

Total current assets

$                  4,856

$                  5,575

Property, plant and equipment – net of accumulated depreciation (June 30,
2026 – $3,694; December 31, 2025 – $3,565)

3,379

3,464

Other Assets

Goodwill

7,840

7,915

Other intangible assets

2,789

2,936

Investments and noncurrent receivables

981

432

Deferred income tax assets

221

282

Deferred charges and other assets

995

971

Total other assets

$                 12,826

$                 12,536

Total Assets

$                 21,061

$                 21,575

Liabilities and Equity

Current Liabilities

Short-term borrowings

$                        —

$                       60

Accounts payable

978

995

Income taxes payable

53

54

Accrued and other current liabilities

970

882

Liabilities of discontinued operations

—

314

Total current liabilities

$                   2,001

$                  2,305

Long-Term Debt

3,125

3,134

Other Noncurrent Liabilities

Deferred income tax liabilities

295

405

Pension and other post-employment benefits – noncurrent

400

432

Other noncurrent obligations

1,359

1,196

Total other noncurrent liabilities

$                   2,054

$                  2,033

Total Liabilities

$                   7,180

$                  7,472

Commitments and contingent liabilities

Stockholders’ Equity

Common stock (authorized 555,555,556 shares of $0.01 par value each;
issued 2026: 135,038,855 shares; 2025: 136,398,482 shares)

1

1

Additional paid-in capital

$                 38,710

38,721

Accumulated deficit

(24,326)

(24,278)

Accumulated other comprehensive loss

(616)

(525)

Total DuPont stockholders’ equity

$                 13,769

$                 13,919

Noncontrolling interests

112

184

Total equity

$                 13,881

$                 14,103

Total Liabilities and Equity

$                 21,061

$                 21,575

 

DuPont de Nemours, Inc.

Consolidated Statement of Cash Flows

Six Months Ended June 30,

In millions (Unaudited)

2026

2025

Operating Activities

Net income (loss)

$                311

$               (511)

Loss from discontinued operations

(30)

(615)

Net income from continuing operations

$                341

$                104

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

309

326

Credit for deferred income tax and other tax related items

45

9

(Earnings) losses of nonconsolidated affiliates (in excess of) less than dividends received

(6)

7

Net periodic pension benefit costs

6

2

Periodic benefit plan contributions

(28)

(23)

Restructuring and asset related charges – net

43

39

Interest rate swap gain

—

(51)

Stock based compensation

27

22

Donatelle contingent earn-out true-up

(14)

(12)

Other net (income) loss

(2)

16

Changes in assets and liabilities, net of effects of acquired and divested companies:

Accounts and notes receivable

(88)

(213)

Inventories

(29)

(51)

Accounts payable

92

(19)

Other assets and liabilities, net

(64)

(5)

Cash provided by operating activities – continuing operations

$                632

$                151

Investing Activities

Capital expenditures

(178)

(172)

Proceeds and adjustments to proceeds from sales of businesses, net of cash divested

1,158

—

Other investing activities, net

9

7

Cash provided by (used for) investing activities – continuing operations

$                989

$              (165)

Financing Activities

Changes in short-term borrowings

(60)

—

Purchases of common stock and forward contracts

(275)

—

Proceeds from issuance of Company stock

107

4

Employee taxes paid for share-based payment arrangements

(22)

(22)

Distributions to noncontrolling interests

(11)

(5)

Dividends paid to stockholders

(163)

(343)

Other financing activities, net

(1)

(7)

Cash used for financing activities – continuing operations

$              (425)

$              (373)

Cash Flows from Discontinued Operations

Cash (used for) provided by operations – discontinued operations

(158)

540

Cash used for investing activities – discontinued operations

(6)

(193)

Cash used for financing activities – discontinued operations

(3)

(17)

Cash (used for) provided by discontinued operations

$              (167)

$                330

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(7)

44

Increase (decrease) in cash, cash equivalents and restricted cash

$             1,022

$                (13)

Cash, cash equivalents and restricted cash from continuing operations, beginning of period

757

1,834

Cash, cash equivalents and restricted cash from discontinued operations, beginning of period

3

58

Cash, cash equivalents and restricted cash at beginning of period

$                760

$             1,892

Cash, cash equivalents and restricted cash from continuing operations, end of period

1,782

1,817

Cash, cash equivalents and restricted cash from discontinued operations, end of period

—

62

Cash, cash equivalents and restricted cash at end of period

$             1,782

$             1,879

 

DuPont de Nemours, Inc.

Select Segment Information and Non-GAAP Measures

Net Sales by Segment

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Healthcare & Water Technologies

$          856

$          817

$        1,662

$        1,580

Diversified Industrials

963

932

1,838

1,781

Total

$        1,819

$        1,749

$        3,500

$        3,361

 

Net Sales Variance by Segment

Three Months Ended June 30, 2026

Organic Sales

Currency

Portfolio / Other

Total

Percent change from prior year (Unaudited)

Healthcare & Water Technologies

4 %

1 %

— %

5 %

Diversified Industrials

3

—

—

3

Total

4 %

— %

— %

4 %

 

Net Sales Variance by Segment

Six Months Ended June 30, 2026

Organic Sales

Currency

Portfolio / Other

Total

Percent change from prior year (Unaudited)

Healthcare & Water Technologies

3 %

2 %

— %

5 %

Diversified Industrials

2

1

—

3

Total

3 %

1 %

— %

4 %

 

Operating EBITDA by Segment

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Healthcare & Water Technologies

$          258

$          248

$          502

$          471

Diversified Industrials

213

199

413

384

Corporate 1

(23)

(24)

(53)

(72)

Total

$          448

$          423

$          862

$          783

1.

Corporate includes expenses of the Corporate function not allocated to specific business in the Company.

Equity in Earnings (Loss) of Nonconsolidated Affiliates by Segment

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Healthcare & Water Technologies

$             1

$            —

$             2

$            —

Diversified Industrials

—

—

(1)

—

Corporate 1

8

9

7

(6)

Total equity earnings (loss) included in operating EBITDA (GAAP)

$             9

$             9

$             8

$            (6)

1.

Corporate includes the equity interest acquired in the Delrin® Divestiture transaction.

 

DuPont de Nemours, Inc.

Selected Financial Information and Non-GAAP Measures

Reconciliation of “Income from continuing operations, net of tax” to
“Operating EBITDA”

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Income from continuing operations, net of tax (GAAP)

$         191

$          24

$         341

$         104

+ Provision for income taxes on continuing operations

75

54

106

71

Income from continuing operations before income taxes

$         266

$          78

$         447

$         175

+ Depreciation and amortization

154

166

309

326

 – Interest income 1, 2

24

18

34

35

 + Interest expense 3

41

84

81

166

 – Non-operating pension/OPEB benefit (costs) credits 1

(1)

—

(1)

2

 – Foreign exchange gains (losses), net 1

4

(14)

14

(17)

+ Future Reimbursable Indirect Costs

—

25

8

50

+ Corporate DDOB Remediation Costs

6

2

10

5

– Significant items charge

(8)

(72)

(54)

(81)

Operating EBITDA (non-GAAP)

$         448

$         423

$         862

$         783

1.

Included in “Sundry income (expense) – net”.

2.

The three and six months ended June 30, 2026 and 2025 excludes accrued interest income earned on employee retention credits. Refer to details of significant items on page 14.

3.

The six months ended June 30, 2025 excludes interest rate swap basis amortization. Refer to details of significant items on page 14.

Reconciliation of “Cash provided by operating activities – continuing
operations” to Adjusted Free Cash Flow 1 , Transaction-Adjusted Free
Cash Flow1 and calculation of “Adjusted Free Cash Flow Conversion”
and “Transaction-Adjusted Free Cash Flow Conversion”

Three Months Ended

Six Months Ended

In millions (Unaudited)

Jun 30, 2026

Jun 30, 2025

Jun 30, 2026

Jun 30, 2025

Cash provided by operating activities (GAAP) 2 – continuing operations

$       400

$        74

$       632

$       151

Capital expenditures

(76)

(50)

(178)

(172)

Adjusted free cash flow (non-GAAP)

$       324

$        24

$       454

$       (21)

Separation-related transaction cost and other payments3

2

83

19

136

Transaction-adjusted free cash flow (non-GAAP)

$       326

$       107

$       473

$       115

Adjusted earnings (non-GAAP) 4

$       257

$       177

$       483

$       331

Adjusted free cash flow conversion (non-GAAP)

126 %

14 %

94 %

(6) %

Transaction-adjusted free cash flow conversion (non-GAAP)

127 %

60 %

98 %

35 %

1

Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow are calculated on a continuing operations basis for all periods presented. Refer to the definitions of Non-GAAP metrics on pages 7-8 for additional information.

2

Refer to the Consolidated Statement of Cash Flows included in the schedules above for major GAAP cash flow categories as well as further detail relating to the changes in “Cash provided by operating activities – continuing operations” for the six month periods noted.

3

Other payments for the three months ended June 30, 2026 includes $2 million related of separation-related capital expenditures. Other payments for the six months ended June 30, 2026 includes $5 million of separation-related capital expenditures, $6 million related to restructuring and short-term incentive program payments associated with former senior leadership, and $8 million for Future Reimbursable Indirect Costs (as defined in our Non-GAAP definitions).

4

Refer to page 14 for the Non-GAAP reconciliations of Net income from continuing operations available for DuPont common stockholders to Adjusted Earnings (Non-GAAP).

 

DuPont de Nemours, Inc.

Selected Financial Information and Non-GAAP Measures

Significant Items Impacting Results for the Three Months Ended June 30, 2026

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported earnings (GAAP)

$     266

$     187

$    1.37

Less: Significant items

Acquisition, integration & separation costs

(7)

(5)

(0.04)

Acquisition, integration and separation costs

Restructuring and asset related benefits – net

3

—

—

Restructuring and asset related charges – net

Other benefits (credits), net 4

(4)

(3)

(0.02)

Sundry income (expense) – net; Selling, general and administrative expenses

Income tax items 5

—

(3)

(0.02)

Provision for income taxes on continuing operations

Total significant items

$      (8)

$     (11)

$   (0.08)

Less: Amortization of intangibles

(68)

(53)

(0.39)

Amortization of intangibles

Less: Non-op pension / OPEB benefit costs

(1)

(1)

(0.01)

Sundry income (expense) – net

Less: Corporate DDOB remediation costs

(6)

(5)

(0.03)

Selling, general and administrative expenses

Adjusted earnings (non-GAAP)

$     349

$     257

$    1.88

 

Significant Items Impacting Results for the Three Months Ended June 30, 2025

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported earnings (GAAP)

$      78

$      24

$    0.17

Less: Significant items

Acquisition, integration and separation costs

(55)

(46)

(0.32)

Acquisition, integration and separation costs

Restructuring and asset related benefits – net

—

1

—

Restructuring and asset related charges – net

Interest rate swap mark-to-market loss 6

(27)

(21)

(0.15)

Sundry income (expense) – net

Other benefits (credits), net 7

10

8

0.06

Sundry income (expense) – net

Income tax items 8

—

(18)

(0.13)

Provision for income taxes on continuing operations

Total significant items

$     (72)

$     (76)

$   (0.54)

Less: Amortization of intangibles

(74)

(58)

(0.42)

Amortization of intangibles

Less: Non-op pension / OPEB benefit credits

—

—

—

Sundry income (expense) – net

Less: Future reimbursable indirect costs

(25)

(19)

(0.14)

Selling, general and administrative expenses

Less: Corporate DDOB remediation costs

(2)

—

—

Selling, general and administrative expenses

Adjusted earnings (non-GAAP)

$     251

$     177

$    1.27

1.

Income (loss) from continuing operations before income taxes.

2.

Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3.

Earnings (loss) per common share from continuing operations – diluted.

4.

Includes benefits related to an adjustment of the Donatelle contingent earn-out liability ($8 million pre-tax benefit) and legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($7 million pre-tax cost), and legal costs associated with personal injury cases associated with Corian® Quartz, a product within the Diversified Industrials segment ($8 million pre-tax cost).

5.

Reflects the net impact of a valuation allowance release in Europe and a deferred tax asset reversal in the U.S.

6.

The three months ended June 30, 2025 includes non-cash mark-to-market loss related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps.

7.

Reflects the accrued interest earned on employee retention credits ($3 million pre-tax benefit), benefits related to an adjustment of the Donatelle contingent earn-out liability ($12 million pre-tax benefit) and legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($5 million pre-tax cost).

8.

Reflects the income tax impact of certain internal restructurings related to the Electronics Separation.

 

DuPont de Nemours, Inc.

Selected Financial Information and Non-GAAP Measures

 

Significant Items Impacting Results for the Six Months Ended June 30, 2026

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported earnings (GAAP)

$     447

$     334

$    2.43

Less: Significant items

Acquisition, integration & separation costs

(7)

(5)

(0.04)

Acquisition, integration and separation costs

Restructuring and asset related charges – net

(43)

(36)

(0.26)

Restructuring and asset related charges – net

Other benefits (credits), net 4

(4)

(3)

(0.02)

Sundry income (expense) – net; Selling, general and administrative expenses

Income tax items 5

—

15

0.11

Provision for income taxes on continuing operations

Total significant items

$     (54)

$     (29)

$   (0.21)

Less: Amortization of intangibles

(136)

(105)

(0.77)

Amortization of intangibles

Less: Non-op pension / OPEB benefit costs

(1)

(1)

(0.01)

Sundry income (expense) – net

Less: Future reimbursable indirect costs

(8)

(6)

(0.04)

Selling, general and administrative expenses

Less: Corporate DDOB remediation costs

(10)

(8)

(0.06)

Selling, general and administrative expenses

Adjusted earnings (non-GAAP)

$     656

$     483

$    3.52

 

Significant Items Impacting Results for the Six Months Ended June 30, 2025

In millions, except per share amounts (Unaudited)

Pretax 1

Net
Income 2

EPS 3

Income Statement Classification

Reported earnings (GAAP)

$     175

$     102

$    0.73

Less: Significant items

Acquisition, integration and separation costs

(105)

(89)

(0.63)

Acquisition, integration and separation costs

Restructuring and asset related charges – net

(39)

(32)

(0.23)

Restructuring and asset related charges – net

Interest rate swap mark-to-market loss 6

50

39

0.28

Sundry income (expense) – net; Interest expense

Other benefits (credits), net 7

13

11

0.08

Sundry income (expense) – net

Income tax items 8

—

(2)

(0.02)

Provision for income taxes on continuing operations

Total significant items

$     (81)

$     (73)

$   (0.52)

Less: Amortization of intangibles

(149)

(117)

(0.84)

Amortization of intangibles

Less: Non-op pension / OPEB benefit credits

2

2

0.01

Sundry income (expense) – net

Less: Future reimbursable indirect costs

(50)

(39)

(0.28)

Selling, general and administrative expenses

Less: Corporate DDOB remediation costs

(5)

(2)

(0.01)

Selling, general and administrative expenses

Adjusted earnings (non-GAAP)

$     458

$     331

$    2.37

1.

Income (loss) from continuing operations before income taxes.

2.

Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

3.

Earnings (loss) per common share from continuing operations – diluted.

4.

Reflects the accrued interest earned on employee retention credits ($3 million pre-tax benefit), benefits related to an adjustment of the Donatelle contingent earn-out liability ($14 million pre-tax benefit), legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($10 million pre-tax cost), and legal costs associated with personal injury cases associated with Corian® Quartz, a product within the Diversified Industrials segment ($11 million pre-tax cost).

5.

Reflects the 2026 income tax benefit primarily the result of a discrete tax benefit relating to a change in tax classification of a non-U.S. legal entity ($20 million pre-tax benefit).

6.

The six months ended June 30, 2025 includes non-cash mark-to-market gain related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps. The six months ended June 30, 2025 also includes basis amortization on the 2022 Swaps ($1 million pre-tax, reflected in “Interest expense” within the Consolidated Statements of Operations).

7.

Reflects the accrued interest earned on employee retention credits ($6 million pre-tax benefit), benefits related to an adjustment of the Donatelle contingent earn-out liability ($12 million pre-tax benefit), legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($5 million pre-tax cost).

8.

Reflects the income tax impact of certain internal restructurings related to the Electronics Separation.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-reports-second-quarter-2026-results-302841628.html

SOURCE DuPont

Continue Reading

Technology

AtkinsRéalis Announces Private Offering of $400 Million of Unsecured Debentures

Published

on

By

MONTREAL, Nov. 9, 2026 /CNW/ — AtkinsRéalis Group Inc. (TSX: ATRL), a world-class engineering services and nuclear company with offices around the world, announced today that it has priced an offering of $400 million aggregate principal amount of 4.062% Series 11 unsecured debentures due November 12, 2029 (the “Debentures”).

Offering of Debentures

The Debentures are being offered through a syndicate of agents led by CIBC Capital Markets, Scotiabank and TD Securities, as joint bookrunners, and which also includes BMO Capital Markets, BNP Paribas (Canada) Securities Inc., National Bank of Canada Capital Markets, RBC Capital Markets, Desjardins Capital Markets and BofA Securities. The Debentures will be issued at a price of $1,000 per $1,000 principal amount of Debentures. AtkinsRéalis intends to use the net proceeds of the offering to repay existing indebtedness and for general corporate purposes.

The Debentures will bear interest at a fixed annual rate of 4.062%, payable in equal semi-annual instalments, in arrears, on May 12 and November 12 of each year until maturity, commencing on May 12, 2027.

The Debentures will be direct unsecured obligations of AtkinsRéalis, will rank pari passu with all other unsecured and unsubordinated indebtedness of AtkinsRéalis (including all of its other existing debentures as well as indebtedness under its existing main credit agreement) and will be guaranteed by the same subsidiaries that guarantee AtkinsRéalis’ obligations under its existing main credit agreement and its other outstanding debentures.

The Debentures have been assigned a provisional rating of BBB with a stable trend by DBRS Limited (Morningstar DBRS) and BBB- by Standard & Poor’s.

The Debentures have not been and will not be qualified for sale to the public under applicable securities laws in Canada and, accordingly, any offer and sale of the Debentures in Canada will be made on a basis which is exempt from the prospectus requirements of such securities laws. No securities regulatory authority has either approved or disapproved of the contents of this press release. The Debentures have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration under, or an applicable exemption from the registration requirements of, the U.S. Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any offer to sell or a solicitation of an offer to buy the Debentures in any jurisdiction where it is unlawful to do so.

About AtkinsRéalis

Created by the integration of long-standing organizations dating back to 1911, AtkinsRéalis is a world-class engineering services and nuclear company dedicated to engineering a better future for our planet and its people. We create sustainable solutions that connect people, data and technology to transform the world’s infrastructure and energy systems. We deploy global capabilities locally to our clients and deliver unique end-to-end services across the whole life cycle of an asset including consulting, advisory & environmental services, intelligent networks & cybersecurity, design & engineering, procurement, project & construction management, operations & maintenance, decommissioning and capital advisory services. The breadth and depth of our capabilities are delivered to clients in strategic sectors such as Engineering Services and Nuclear, as steward of CANDU® nuclear technology. News and information are available at www.atkinsrealis.com or follow us on LinkedIn.  

Forward-Looking Statements
References in this press release, and hereafter, to the “Company”, “AtkinsRéalis”, “we”, “us” and “our” mean, as the context may require, AtkinsRéalis Group Inc. and all or some of its subsidiaries or joint arrangements or associates, or AtkinsRéalis Group Inc. or one or more of its subsidiaries or joint arrangements or associates.

Statements made in this press release, including, but not limited to, statements relating to the offering of the Debentures, or any other future events or developments and other statements that are not historical facts, constitute “forward-looking statements” which can be identified by the use of the conditional or forward-looking terminology such as “aims”, “anticipates”, “assumes”, “believes”, “cost savings”, “estimates”, “expects”, “forecasts”, “goal”, “intends”, “likely”, “may”, “objective”, “outlook”, “plans”, “projects”, “should”, “synergies”, “target”, “vision”, “will”, or the negative thereof or other variations thereon.

Specific forward-looking statements in this press release include, but are not limited to, statements with respect to the offering of the Debentures and the intended timing and use of proceeds thereof and to the credit ratings assigned to the Debentures. All such forward-looking statements are made pursuant to the “safe-harbour” provisions of applicable Canadian securities laws. The Company cautions that, by their nature, forward-looking statements involve risks and uncertainties, and that its actual actions and/or results could differ materially from those expressed or implied in such forward-looking statements, or could affect the extent to which a particular projection materializes. Forward-looking statements are presented for the purpose of assisting investors and others in understanding certain key elements of the Company’s current objectives, strategic priorities, expectations and plans, and in obtaining a better understanding of the Company’s business and anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes.

Forward-looking statements made in this press release are based on a number of assumptions believed by the Company to be reasonable as at the date of this press release. The assumptions are set out throughout the Company’s 2025 annual management’s discussion and analysis (“2025 MD&A”) (particularly in the sections entitled “Critical Accounting Judgements and Key Sources of Estimation Uncertainty” and “How We Analyze and Report Our Results”) filed with the securities regulatory authorities in Canada, available on SEDAR+ at www.sedarplus.ca and on the Company’s website at www.atkinsrealis.com  under the “Investors” section. If these assumptions are inaccurate, the Company’s actual results could differ materially from those expressed or implied in such forward-looking statements. In addition, important risk factors could cause the Company’s assumptions and estimates to be inaccurate and actual results or events to differ materially from those expressed in or implied by these forward-looking statements. Those risks are identified in the 2025 MD&A (particularly in the section entitled “Risks and Uncertainties”) and may be updated from time to time in the Company’s 2026 interim quarterly management’s discussion and analysis.

The forward-looking statements herein reflect the Company’s expectations as at the date of this press release and are subject to change after this date. The Company does not undertake to update publicly or to revise any written or oral forward-looking information or statements, whether as a result of new information, future events or otherwise, unless required by applicable legislation or regulation. The forward-looking information and statements contained herein are expressly qualified in their entirety by this cautionary statement.

For More Information :

Media             

Investors   

Antoine Calendrier           

Denis Jasmin   

Vice President, Global External 

Vice President, Investor Relations   

Communications

514-393-8000, ext. 57553  

media@atkinsrealis.com 

denis.jasmin@atkinsrealis.com 

SOURCE AtkinsRéalis

Continue Reading

Technology

Korea Deep Learning Cuts Financial Document Processing Time by 88%, Targets APAC Financial Sector

Published

on

By

VLM-based AI agent demonstrates potential in automating complex financial workflows through joint PoC with South Korea’s Industrial Bank of KoreaKorean AI company advances PoC discussions with nine Japanese financial institutions following projects in Vietnam and Taiwan region

SEOUL, South Korea, Nov. 10, 2026 /PRNewswire/ — Korea Deep Learning (KDL), an enterprise AI agent company, is expanding its presence in the Asia-Pacific financial sector following a successful proof of concept (PoC) with South Korea’s Industrial Bank of Korea (IBK), which demonstrated an 88% reduction in financial document processing time.

The project applied KDL’s VLM-based AI agent, DEEP Agent for Finance, to automate document-intensive procedures for handling voice phishing relief cases. The solution combines document recognition, information extraction and crime-type inference, addressing tasks that traditionally require substantial manual review by financial institution employees.

During the PoC, the system achieved 100% accuracy in printed-text recognition and document classification, while handwriting recognition accuracy exceeded 97%, based on the project’s evaluation criteria. All key performance indicators exceeded their targets using actual business data. The solution was deployed within IBK’s closed network, with employee review retained for cases requiring additional verification.

The results provide a reference case for KDL as it pursues opportunities with financial institutions across Asia. The company has completed a separate PoC with Shinhan Vietnam Finance Company (SVFC), a local subsidiary of Shinhan Card, through the Shinhan Financial Group’s open innovation program. KDL has also supplied AI solutions in overseas markets including Vietnam and Taiwan region.

In Japan, KDL is advancing discussions about potential PoCs with nine financial institutions. It is also engaging with financial institutions across the region in banking, insurance and consumer finance. Some prospective partners have signed non-disclosure agreements and are evaluating the technology using actual business data.

KDL plans to convert ongoing technical evaluations into paid PoCs and supply contracts, while developing local partnerships and sales channels from 2027. The company also aims to extend its solutions beyond banking into insurance and securities, where document processing and information extraction remain important parts of daily operations.

“Financial institutions handling voice phishing relief cases often spend considerable time processing documents before they can focus on supporting customers,” said Ji-hyun Kim, CEO of Korea Deep Learning. “Our project with IBK demonstrates how VLM-based AI agents can reduce that administrative burden. We aim to help financial institutions automate repetitive tasks, improve operational efficiency and allocate more resources to consumer protection.”

About Korea Deep Learning

Founded in 2019, Korea Deep Learning is an enterprise AI agent company specializing in document intelligence and workflow automation. Its DEEP Agent platform combines DEEP OCR and DEEP Parser technologies to extract and process information from complex documents. The company serves more than 80 companies and public institutions in South Korea.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/korea-deep-learning-cuts-financial-document-processing-time-by-88-targets-apac-financial-sector-302931894.html

SOURCE Korea Deep Learning

Continue Reading

Technology

LG Innotek Shines Again in Vehicle Lighting with Third Consecutive CES Innovation Award

Published

on

By

Next-generation vehicle lighting module Nexlide C+ wins CES 2027 Innovation AwardDifferent light patterns appear depending on the viewing angle, even from a single lighting moduleWorld’s first use of optical films in an ultra-slim surface light source module, enabling a thinner design

SEOUL, South Korea, Nov. 9, 2026 /PRNewswire/ — LG Innotek (CEO Moon Hyuksoo, 011070) announced on November 9 that its next-generation vehicle lighting module, Nexlide C+, has received a CES (Consumer Electronics Show) 2027 Innovation Award.

With its Nexlide series, LG Innotek has now received CES Innovation Awards for three consecutive years, from 2025 through 2027. The latest recognition reaffirms the company’s world-class competitiveness in vehicle lighting technology.

Nexlide is LG Innotek’s brand of next-generation flexible vehicle lighting modules, which combine the company’s proprietary optical design with advanced materials technology. Built on surface light source technology, which emits light in a broad and uniform fashion, Nexlide modules are thinner and more compact than conventional vehicle lighting while allowing a wide range of design possibilities. LG Innotek holds more than 700 patents related to surface light source technology.

The key strength of the award-winning Nexlide C+ is that a single lighting module can produce two or more 3D images, known as the 3D Multi-Effect. For example, the same module displays a 3D image with a diagonal pattern when viewed from the left and a vertical pattern when viewed from the right. Because the image changes with the viewing angle, the lighting creates a dynamic visual effect with a sense of depth.

Nexlide C+ can be integrated into various parts of a vehicle, from exterior lighting such as taillights and front grille lights to interior ambient lighting.

An LG Innotek official said, “Vehicle lighting is evolving from a simple signaling function into a key factor that shapes the design competitiveness of an automaker’s brand. Lighting technologies like Nexlide C+ that are capable of creating diverse light patterns will see even wider use.”

Nexlide C+ is also ultra-slim, at just 3 mm (0.12 in) thick or less, allowing it to be installed in tight spaces within a vehicle. LG Innotek is the first in the world to apply Light Turning Film and 3D Micro-Optic Pattern Film to an ultra-slim surface light source module.

The Light Turning Film precisely controls the direction of light to make different images appear at different viewing angles, while the 3D Micro-Optic Pattern Film makes images look three-dimensional even on a flat lighting surface.

The two films are only about 0.16 mm (0.0063 in) and 0.13 mm (0.0051 in) thick, respectively. By incorporating these ultra-thin films into the lighting module, LG Innotek enables a variety of 3D lighting effects in a slim profile. Previously, achieving the same effects required optical components such as plastic lenses and reflectors, and installing multiple components made the lighting unit bulkier.

By using these films to reduce the thickness of the lighting module, Nexlide C+ gives automakers even greater design freedom.

Going forward, LG Innotek will actively promote Nexlide C+ to global automakers and parts suppliers, targeting a 2027 launch.

At CES 2027 in January, LG Innotek will showcase a broad lineup of next-generation vehicle lighting modules, including Nexlide C+, along with key components for various areas of physical AI, such as autonomous driving and robotics.

[Background] LG Innotek previously received a CES 2025 Innovation Award for Nexlide A+, the industry’s first vehicle front lighting module to apply surface light source technology, with 40% less thickness and more than five times the brightness of the previous product. At CES 2026, the company received another Innovation Award for Nexlide Pixel, which reduced the lighting pixel size to among the smallest in the world while improving luminous efficiency by 30% compared with the previous product.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lg-innotek-shines-again-in-vehicle-lighting-with-third-consecutive-ces-innovation-award-302933258.html

SOURCE LG Innotek

Continue Reading

Trending